ANTI-RHEUMATIC NONSTEROID DRUGS IN THERAPY OF PATIENTS WITH RHEUMATOID-ARTHRITIS

被引：0
|
作者：
DORMIDONTOV, EN
KORSHUNOV, NI
BARANOVA, EY
机构：
来源：
TERAPEVTICHESKII ARKHIV | 1978年 / 50卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：10 / 13
页数：4
相关论文
共 50 条
  • [41] PREDICTORS OF INTENSIVE ANTI-RHEUMATIC THERAPY IN EARLY CARE FOR RHEUMATOID ARTHRITIS
    Chiarelli, L.
    Tavares, R.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 770 - 771
  • [42] TISSUE-CULTURE MODEL OF CARTILAGE BREAKDOWN IN RHEUMATOID-ARTHRITIS .3. EFFECTS OF ANTI-RHEUMATIC DRUGS
    STEINBERG, J
    TSUKAMOTO, S
    SLEDGE, CB
    [J]. ARTHRITIS AND RHEUMATISM, 1979, 22 (08): : 877 - 885
  • [43] Disease-modifying anti-rheumatic drugs in rheumatoid arthritis and ankylosing spondylitis
    Haibel, H.
    Specker, C.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2009, 27 (04) : S159 - S163
  • [44] Monotherapy with biologic disease-modifying anti-rheumatic drugs in rheumatoid arthritis
    Choy, Ernest
    Aletaha, Daniel
    Behrens, Frank
    Finckh, Axel
    Gomez-Reino, Juan
    Gottenberg, Jacques-Eric
    Schuch, Florian
    Rubbert-Roth, Andrea
    [J]. RHEUMATOLOGY, 2017, 56 (05) : 689 - 697
  • [45] Assessment of adherence to disease-modifying anti-rheumatic drugs in rheumatoid arthritis
    Monchablon, Clelia
    Gonde, Henri
    Pouplin, Sophie
    Varin, Remi
    Vittecoq, Olivier
    Lequerre, Thierry
    [J]. CLINICAL RHEUMATOLOGY, 2020, 39 (01) : 207 - 216
  • [46] Toxicity of anti-rheumatic drugs in a randomized clinical trial of early rheumatoid arthritis
    van Jaarsveld, CHM
    Jahangier, ZN
    Jacobs, JWG
    Blaauw, AAM
    van Albada-Kuipers, GA
    ter Borg, EJ
    Brus, HLM
    Schenk, Y
    van der Veen, MJ
    Bijlsma, JWJ
    [J]. RHEUMATOLOGY, 2000, 39 (12) : 1374 - 1382
  • [47] Assessment of adherence to disease-modifying anti-rheumatic drugs in rheumatoid arthritis
    Clélia Monchablon
    Henri Gondé
    Sophie Pouplin
    Rémi Varin
    Olivier Vittecoq
    Thierry Lequerré
    [J]. Clinical Rheumatology, 2020, 39 : 207 - 216
  • [48] SLOW ONSET ANTI-RHEUMATIC DRUGS IN RHEUMATOID-ARTHRITIS - COULD THE PRESENCE OF ANTI-NUCLEAR ANTIBODY INFLUENCE THE THERAPEUTIC RESULTS
    MENARD, H
    MATHIEU, J
    MEDICIS, RD
    LUSSIER, A
    [J]. JOURNAL OF RHEUMATOLOGY, 1979, 6 (02) : 156 - 162
  • [49] The anti-rheumatic effect of multiple synovectomy in patients with refractory rheumatoid arthritis
    Nakamura, H
    Nagashima, M
    Ishigami, S
    Wauke, K
    Yoshino, S
    [J]. INTERNATIONAL ORTHOPAEDICS, 2000, 24 (05) : 242 - 245
  • [50] DISEASE MODIFYING ANTI-RHEUMATIC DRUG (DMARD) TREATMENT OF CLASSICAL RHEUMATOID-ARTHRITIS (RA)
    RASMUSSEN, EK
    HALBERG, P
    [J]. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 1984, : 122 - 122
12345